Two Sigma Advisers
SLDB icon

Two Sigma Advisers’s Solid Biosciences SLDB Stock Holding History

Two Sigma Advisers’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,373
Closed -$97.5K – 2565
2024
Q4 		$97.5K Sell
24,373
-36,200
-60% -$199K ﹤0.01% 2223
2024
Q3 		$422K Buy
60,573
+35,573
+142% +$288K ﹤0.01% 1770
2024
Q2 		$142K Buy
25,000
+10,500
+72% +$94K ﹤0.01% 2275
2024
Q1 		$193K Buy
+14,500
New +$136K ﹤0.01% 2218
2022
Q4 		– Sell
-12,473
Closed -$87K – 2678
2022
Q3 		$87K Sell
12,473
-2,634
-17% -$26.6K ﹤0.01% 2327
2022
Q2 		$139K Sell
15,107
-9,760
-39% -$101K ﹤0.01% 2349
2022
Q1 		$448K Sell
24,867
-13,446
-35% -$237K ﹤0.01% 2040
2021
Q4 		$1.01M Buy
38,313
+1,793
+5% +$54.8K ﹤0.01% 1558
2021
Q3 		$1.31M Sell
36,520
-62,387
-63% -$2.65M ﹤0.01% 1485
2021
Q2 		$5.43M Buy
98,907
+53,307
+117% +$3.52M 0.01% 827
2021
Q1 		$3.78M Buy
45,600
+24,427
+115% +$2.7M 0.01% 975
2020
Q4 		$2.41M Buy
21,173
+10,466
+98% +$662K 0.01% 1157
2020
Q3 		$326K Buy
10,707
+947
+10% +$36.3K ﹤0.01% 1982
2020
Q2 		$429K Buy
9,760
+4,013
+70% +$167K ﹤0.01% 1963
2020
Q1 		$206K Buy
5,747
+4,894
+574% +$242K ﹤0.01% 2162
2019
Q4 		$57K Buy
+853
New +$94.1K ﹤0.01% 2287

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers's SLDB Position: Q1 2025 in Review

Two Sigma Advisers sold out of Solid Biosciences (SLDB) in Q1 2025, closing a stake of 24,373 shares — an estimated $97.5K sold.

Two Sigma Advisers first reported a position in SLDB in Q4 2019 and held it in 16 quarters. The position peaked at $5.43M in Q2 2021. 124 funds tracked by Wall St. Rank hold SLDB as of Q1 2025.

  • Two Sigma Advisers reported no remaining Solid Biosciences position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 24,373 Solid Biosciences shares in Q1 2025, an estimated $97.5K.
  • Two Sigma Advisers first reported a position in Solid Biosciences in Q4 2019 and held it in 16 quarters.
  • Two Sigma Advisers's Solid Biosciences position peaked at $5.43M in Q2 2021.
  • 124 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2025.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.